scispace - formally typeset
I

Irving Franco

Researcher at Cleveland Clinic

Publications -  63
Citations -  2179

Irving Franco is an academic researcher from Cleveland Clinic. The author has contributed to research in topics: Angioplasty & Myocardial infarction. The author has an hindex of 27, co-authored 63 publications receiving 2134 citations. Previous affiliations of Irving Franco include Cairo University.

Papers
More filters
Journal ArticleDOI

Frequency, management and follow-up of patients with acute coronary occlusions after percutaneous transluminal coronary angioplasty.

TL;DR: Redilation is a safe and effective approach to manage patients in whom coronary occlusion develops after PTCA, and only the presence of eccentric lesions and intimal tears was more predominant in the group with acute occlusions.
Journal ArticleDOI

Percutaneous transluminal angioplasty of saphenous vein graft stenosis: long-term follow-up.

TL;DR: The complication and recurrence rates of saphenous vein graft angiography are significantly higher when performed for late (greater than 36 months) vein graft failure, and all therapeutic options should be carefully examined before proceeding with angioplasty.
Journal ArticleDOI

Relation of clinical presentation, stenosis morphology, and operator technique to the procedural results of rotational atherectomy and rotational atherectomy-facilitated angioplasty.

TL;DR: The procedural outcome of rotational atherectomy is highly correlated with stenosis morphology and location and sex of the patient, and overall outcome with the Rotablator appears to be similar to that with balloon angioplasty and other competing techniques.
Journal ArticleDOI

The dilemma of diagnosing coronary calcification: angiography versus intravascular ultrasound.

TL;DR: Despite poor sensitivity, angiography may help identify patients requiring intravascular ultrasound, and patients without angiographic calcification in the coronary tree may not need routine ultrasound examination, as the likelihood of >90 degrees superficial calcium is low.
Journal ArticleDOI

Safety of femoral closure devices after percutaneous coronary interventions in the era of glycoprotein IIb/IIIa platelet blockade.

TL;DR: Femoral closure devices have a similar overall risk profile as manual compression, even in patients treated with glycoprotein IIb/IIIa platelet inhibition, although certain rare complications such as retroperitoneal hemorrhage and severe access-site infection may be more common with the use of these devices.